All times mentioned are CEST.
Zielsetzung
This is an advanced level course divided into two parts.
You will learn:
- What is Ongoing/Continued Process verification
- Overview of Control Charts of grouped and individual data
- Overview of Three-Way charts
- Overview of Attributes charts
- Stability and capability of a process
- Tools for detecting a trend and shift in process average and/or process variability
- Reasons for too many statistical false signals in real-life process data
- Ways to minimize false signals in real-life pharmaceutical and biopharmaceutical processes
- Components of a CPV/OPV plan
- Integration a practical SPC approach into the CPV/OPV plan
- Examples of control charts of real-life data of pharmaceutical processes, generated with StatGraphics, will be shown throughout the course
Hintergrund
FDA´s Process Validation Guidance and Annex 15 to the EU GMP Guide require manufacturers to monitor product quality to ensure that a state of control is maintained throughout the validation lifecycle of new products and legacy products during the third process validation stage called Continued Process Verification (CPV) or Ongoing Process Verification (OPV). Indeed, regulatory agencies expect manufacturers to implement also a CPV plan as reflected in FDA warning letters.
The implementation of Stage 3 is translated into establishing an ongoing CPV/OPV program which allows Identification of CPV/OPV signals and defining types of responses to these signals. However, real-life data of pharmaceutical and biopharmaceutical processes rarely meet the fundamental assumtioms of the conventional SPC (Statistical Process Control), This in turn leads often to false signal alarms, which entail futile investigations of innocuous events. Thus, a practical approach is called for and it consists of collecting, charting and evaluating product and process data under relaxed and adjusted SPC rules, allowing a streamlined implementation of the CPV/OPV program.
Zielgruppe
This is an advanced level course, therefore a knowledge on control charts is an advantage. Experienced employees from companies, who are involved in pharmaceutical process validation activities (developers, QM, manufacturing, heads of validation departments, etc.) especially regarding stage 3 ongoing/continued process verification, are addressed. Of course consultants in this field, who want to get information from the view of the medicinal product manufacturers, are addressed too.
Technical Requirements
We use Webex Events for our live online training courses and webinars. At www.gmp-compliance.org/training/online-training-technical-information you will find all the information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.
Programm
Introduction
- What is Ongoing/Continued Process Verification
- Regulations
- What data to trend
- Process inputs and outputs: CPP and CQA
- NOR, PAR and Design Space
- Run Chart versus Control Chart
- Common cause variation versus special variation
- “State of Control”
Overview of Control Charts of Variables
- Overview of Control Charts of grouped data
- Overview of Control Charts of individual data
- Overview of Three-Way charts
- Capability indices (Cp, Cpk, Pp and Pk)
- Stability and capability of a process
- Examples: control charts of Assay, impurity, of UOC, dissolution
Overview of Control Charts of Attributes
- Their use in the pharmaceutical industry
- Np and p control charts
- c and u control charts
- xamples: control Np charts of inspected packages (defective), c charts of non-conformities (defects)
- in labels of a drug product; c chart of environmental microbial counts
Evaluation of a Control Chart
- Nelson rules for detecting trends and shifts
- “State of Control” versus “State of Statistical Control”
- Phase I and Phase II in control charting
- “Statistical Limits” versus “Regulatory Limits”
- Are all statistical assumptions valid in real-world pharmaceutical process data?
Adjusting SPC Rules to Pharmaceutical Process Data
- Which statistical rules can be relaxed
- Setting practical limits
- Examples of process behaviour charts
- Components of a CPV/OPV Plan
- Identification of CPV signals
- Types of responses to signals
Structure of OPV/CPV Plan
- Basic components of an OPV/CPV Plan
- Set of SOPs
- Identification of OPV/CPV signals
- What level of monitoring?
- Types of responses to OPV/CPV signals
- Roadmap of OPV/CPV Plan
Diese Veranstaltung ist derzeit nicht buchbar. Alternative Live-Veranstaltungen und Aufzeichnungen finden Sie in der Gesamtübersicht. Oder kontaktieren Sie uns gerne über das Kontaktformular.
* auch unkompliziert per Kreditkarte bezahlbar
Aufzeichnung/weitere Termine nicht verfügbar
Aufzeichnung/weitere Termine nicht verfügbar
This course is part of the GMP Certification Programme "ECA Certified Validation Manager"
Haben Sie noch Fragen?
Wir stehen Ihnen für weitere Auskünfte gerne zur Verfügung.
E-Mail: info@concept-heidelberg.de
Teilnehmerstimmen
Teilnehmerstimmen - das sagen andere über unsere Seminare:
